1. Home
  2. FRPT vs TMDX Comparison

FRPT vs TMDX Comparison

Compare FRPT & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Freshpet Inc.

FRPT

Freshpet Inc.

HOLD

Current Price

$64.25

Market Cap

3.0B

ML Signal

HOLD

Logo TransMedics Group Inc.

TMDX

TransMedics Group Inc.

HOLD

Current Price

$71.26

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FRPT
TMDX
Founded
2004
1998
Country
United States
United States
Employees
N/A
898
Industry
Packaged Foods
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
2.5B
IPO Year
2014
2019

Fundamental Metrics

Financial Performance
Metric
FRPT
TMDX
Price
$64.25
$71.26
Analyst Decision
Buy
Buy
Analyst Count
18
13
Target Price
$83.50
★ $98.73
AVG Volume (30 Days)
★ 941.6K
716.7K
Earning Date
11-04-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
183.87
★ 382.18
EPS
★ 1.29
0.61
Revenue
★ $1,102,015,000.00
$605,494,000.00
Revenue This Year
$11.17
$22.57
Revenue Next Year
$8.52
$17.85
P/E Ratio
★ $52.18
$118.03
Revenue Growth
13.01
★ 37.13
52 Week Low
$46.45
$60.11
52 Week High
$86.00
$156.00

Technical Indicators

Market Signals
Indicator
FRPT
TMDX
Relative Strength Index (RSI) 49.87 35.14
Support Level $56.79 $66.64
Resistance Level $68.77 $71.14
Average True Range (ATR) 2.67 3.93
MACD 0.24 -0.60
Stochastic Oscillator 43.90 21.18

Price Performance

Historical Comparison
FRPT
TMDX

About FRPT Freshpet Inc.

Freshpet produces and sells premium fresh pet food through its company-owned refrigerators placed in grocery, mass and club, pet specialty, and natural stores. Freshpet primarily targets dogs (likely representing well north of 90% of sales), with cats and treats nascent contributors. Geographically, the company's home US market, where all its food is produced, accounts for nearly all of sales, with exports to Canada, the United Kingdom, and other European countries being very small contributors.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: